Progesterone Attenuates Allodynia of Inflamed Temporomandibular Joint through Modulating Voltage-Gated Sodium Channel 1.7 in Trigeminal Ganglion

11Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Women with temporomandibular disorders (TMDs) experience some amelioration of pain during pregnancy. Progesterone increases dramatically and steadily during pregnancy. Sodium channel 1.7 (Nav1.7) plays a prominent role in pain perceptions, as evidenced by deletion of Nav1.7 alone leading to a complete loss of pain. In a previous study, we showed that Nav1.7 in trigeminal ganglion (TG) is involved in allodynia of inflamed temporomandibular joint (TMJ). Whether progesterone modulates allodynia of inflamed TMJ through Nav1.7 in TG remains to be investigated. Methods. The effects of progesterone on sodium currents of freshly isolated TG neurons were examined using whole-cell recording. Female rats were ovariectomized and treated with increasing doses of progesterone for 10 days. Complete Freund's adjuvant was administered intra-articularly to induce TMJ inflammation. TMJ nociceptive responses were evaluated by head withdrawal thresholds. Real-time PCR and Western blotting were used to examine Nav1.7 mRNA and protein expression in TG. Immunohistofluorescence was used to examine the colocalization of progesterone receptors (PRα/β) and Nav1.7 in TG. Results. Whole-cell recording showed that progesterone could attenuate sodium currents. Moreover, progesterone dose-dependently downregulated Nav1.7 mRNA expression and reduced the sensitivity of TMJ nociception in ovariectomized rats. Furthermore, treatment with progesterone attenuated allodynia of inflamed TMJ in a dose-dependent manner and repressed inflammation-induced Nav1.7 mRNA and protein expression in ovariectomized rats. The progesterone receptor antagonist, RU-486, partially reversed the effect of progesterone on allodynia of inflamed TMJ and TMJ inflammation-induced Nav1.7 mRNA and protein expression. Conclusion. Progesterone, by modulating trigeminal ganglionic Nav1.7, may represent a promising agent to prevent allodynia of inflamed TMJ.

References Powered by Scopus

An SCN9A channelopathy causes congenital inability to experience pain

1311Citations
N/AReaders
Get full text

Nociceptor-specific gene deletion reveals a major role for Na<inf>v</inf> 1.7 (PN1) in acute and inflammatory pain

592Citations
N/AReaders
Get full text

Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons

465Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tmd in females with menstrual disorders

21Citations
N/AReaders
Get full text

Preclinical models of deep craniofacial nociception and temporomandibular disorder pain

9Citations
N/AReaders
Get full text

Systemic Factors in Temporomandibular Disorder Pain

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bi, R. Y., Zhang, X. Y., Zhang, P., Ding, Y., & Gan, Y. H. (2020). Progesterone Attenuates Allodynia of Inflamed Temporomandibular Joint through Modulating Voltage-Gated Sodium Channel 1.7 in Trigeminal Ganglion. Pain Research and Management, 2020. https://doi.org/10.1155/2020/6582586

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Researcher 2

22%

Professor / Associate Prof. 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

67%

Pharmacology, Toxicology and Pharmaceut... 1

11%

Nursing and Health Professions 1

11%

Neuroscience 1

11%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free